Viewing Study NCT02923466


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2025-12-24 @ 4:13 PM
Study NCT ID: NCT02923466
Status: COMPLETED
Last Update Posted: 2022-04-27
First Post: 2016-09-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors
Sponsor: Vyriad, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module